The Drug Monitor
Please read the Disclaimer
 

Antiinfectives

General Rx

Renal Rx

Transplant Rx

Pkinetics

Educational

KidneyWorks

Clinical Tools

CVVH Initial Drug Dosing Guidelines
Provided to the Drug Monitor by
Dr. Bruce Mueller
Updated 5/5/2000

These initial dosing guidelines are applicable to adult patients with anuric / oliguric acute renal failure, normal hepatic function, and an ultrafiltration rate of 1 Liter / hour. These are recommendations for initial dosing only. Subsequent dosage adjustments should be guided by serum levels and clinical judgement.

DrugLoading DoseMaintenance Dose
Acyclovir
-----
5 mg/kg Q12H
Amikacin
7.5 mg/kg
7.5 mg/kg Q24H
Aztreonam:
2 g
1 g Q12H
Cefepime:
2 g
1 g Q12H
Cefoperazone
2 g
1 g Q12H
Ceftazidime
2 g
1 g Q12H
Cimetidine
-----
300 mg Q8H or
900 mg/24H in TPN
Ciprofloxacin
-----
400 mg Q24H
Co-trimoxazole
(SMX/TMP)(IV)
-----
2.5 mg/kg TMP Q8H
Fluconazole
400 mg
200 mg Q24H
Gent/Tobra
2 mg/kg
1.5 - 2 mg/kg Q24H
Ganciclovir
-----
2 mg/kg Q24H
Imipenem
-----
500 mg Q8H
Metronidazole
1 g
500 mg Q8H
Piperacillin
-----
3 g Q8H
Procainamide (IV)
1 - 2 g
1 mg/min
Ranitidine (IV)
-----
150 mg/24H in TPN or
50 mg Q8-12H
Vancomycin
15 mg/kg
10 mg/kg Q24H
Vitamins: supplement water soluble vitamins or double MVI
Pressors, analgesics, paralytics, and anxiolytics are titrated to response
For a primer on CVVH and other modalities of continuous renal replacement therapy (CRRT) the reader is referred to the 3/98 issue of The Annals of Pharmacotherapy '98; 32:362-374.

References on drug dosing in CRRT:

  1. Schetz M, Ferdinande P, Van den Berghe G et al. Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 1995;21:612-620.
  2. Golper TA, Marx MA. Drug dosing adjustments during continuous renal replacement therapies. Kidney Int 1998;53 suppl 66: S165-168.

 

Copyrights ® 1997-2002 the Drug Monitor